mTOR and AMP-Activated Protein Kinase in Obesity and Cancer

dc.contributor.authorBiswas, Indranil
dc.contributor.authorMaurya, Shashank Kumar
dc.contributor.authorSenapati, Sabyasachi
dc.date.accessioned2024-01-21T10:54:01Z
dc.date.accessioned2024-08-14T07:40:47Z
dc.date.available2024-01-21T10:54:01Z
dc.date.available2024-08-14T07:40:47Z
dc.date.issued2021-07-18T00:00:00
dc.description.abstractThe mTOR (mechanistic target of rapamycin) is the main regulator of important cellular processes, including cellular growth, proliferation, protein synthesis, protein remodeling, autophagy, and cell metabolism in response to nutrition status, growth factor, and stress signals. Previous studies demonstrated that mTOR signaling plays a crucial role in the function of adipose tissue such as adipogenesis, lipid metabolism, thermogenesis, and adipokine biosynthesis and release. Nutritional status in adipose tissues is different than its surrounding microenvironment, which receive altered metabolic ques. from the adipose tissues. In regard to its critical role in cellular processes, it is expected that obesity and related metabolic disorders will have direct role in dysregulation of mTOR signaling. Aberrant mTOR signaling is commonly observed in different types of cancer. Hyperactivation of mTORC1 pathway activates cell proliferation and decreased autophagy, which leads to initiation of tumor growth, progression, and angiogenesis. Another regulator of metabolic activity, adenosine monophosphate (AMP)-activated protein kinase (AMPK), maintains the energy homeostasis in response to metabolic alteration. Previous research demonstrated that AMPK is a key cellular energy sensor responsible for regulating the metabolic activity of brown and beige adipose tissues. AMPK has also been demonstrated to negatively regulate diabetes, cardiovascular disease, and other metabolic syndromes. Apart from metabolic syndrome and diabetes, the AMPK signaling has shown therapeutic potential due to its unique potential in regulating of cancer cell proliferation via cell metabolism reprogramming.. Previous reports suggest the tumor suppressive role of AMPK that sense the energy deficiency in solid tumors, thereby inhibit the cellular proliferation. However, recent data proposes that tumor cells gain growth advantage in oxygen and nutrient deprived condition via exploiting AMPK activation. In light of adipose tissue associated tumors, it is well known that adipose tissues activate inflammation in response oxygen deprivation. However, the role of altered metabolism, specifically interaction between adipose tissues and tumor microenvironment, in terms of mTOR and AMPK signaling is not well known. � The Editor(s) (if applicable) and The Author(s), under exclusive license to Taylor and Francis Pte Ltd. 2021.en_US
dc.identifier.doi10.1007/978-981-16-1846-8_5
dc.identifier.isbn9789811618468
dc.identifier.isbn9789811618451
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/4188
dc.identifier.urlhttps://link.springer.com/10.1007/978-981-16-1846-8_5
dc.language.isoen_USen_US
dc.publisherSpringer Singaporeen_US
dc.subjectAdipogenesisen_US
dc.subjectAMPKen_US
dc.subjectMTORen_US
dc.subjectObesityen_US
dc.subjectTumor growthen_US
dc.titlemTOR and AMP-Activated Protein Kinase in Obesity and Canceren_US
dc.title.journalObesity and Canceren_US
dc.typeBook chapteren_US
dc.type.accesstypeClosed Accessen_US

Files